Cookies disclaimer

Continue Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device. Additional information can be found under the cookie section of this page.

Eu2P Master degree in Pharmacovigilance and Pharmacoepidemiology    Back

Eu2P Course Type: Master taught/research Start Date: September
Duration: see details Fees/total cost: EUR 14,000.00

Description

The Eu2P Master is an academic post-graduate diploma in pharmacovigilance and pharmacoepidemiology jointly delivered by the seven European academic bodies working together as Eu2P partners.

The Eu2P European Master is built and recognised by all the 24 academic, regulatory and industrial Eu2P partners. Eu2P courses are grounded in real job market and today's practices and research projects can be performed in public or private environments.

Eu2P programme is being noticed and recognised world-wide* as an excellent opportunity to get jobs and improve regulatory sciences.

In second year, choose a Master specialization among Benefit assessment of medicines, Medicines risk identification and quantification, Medicines benefit-risk assessment, Medicines and public health, Medicines risk communication domains or select "à la carte" modules to match specific needs.

Awarded for e-learning quality, Eu2P online courses can be attended at home and work. See Eu2P Training Excellence.

Master year 1 or 2 curriculum can be performed on a full or part time basis to suit your time availiability.

Scholarships and fees discouts can be offered under eligibility conditions.

Masters - Full time

Start date:
September
Duration:
2 Years
Teaching method:
Distance Learning
Language:
English
Funding possible:
Yes
EU-Fees:
EUR 14,000.00
Non-EU-Fees:
EUR 14,000.00

Masters - Part time

Start date:
September
Duration:
4 Years
Teaching method:
Distance Learning
Language:
English
Funding possible:
Yes
EU-Fees:
EUR 14,000.00
Non-EU-Fees:
EUR 14,000.00

PharmaTrain Recognition


Click to see the benefits of a PharmaTrain approved course.

LifeTrain

Course Provider Details

Course contact information


Eu2P Central office
contact@eu2p.org

Recognised by

University accredited:
Credits:
120 ECTS

Modules

Module name Credits (ECTS or CATS) Duration Core / elective / recommended Available as Short course (CPD)
Basics in clinical pharmacology 3 ECTS credits core Yes
Basics in epidemiology applied to pharmacovigilance and pharmacoepidemiology 3 ECTS credits Part time - 3 Months core Yes
Basics in medicines risk communication 3 ECTS credits Part time - 3 Months core Yes
Basics in pharmacoepidemiology 3 ECTS credits Full time - 3 Months core Yes
Basics in statistics applied to pharmacovigilance and pharmacoepidemiology 3 ECTS credits Part time - 3 Months core Yes
Clinical and pharmacological principles 3 ECTS credits Part time - 3 Months core Yes
Drug utilisation studies: introduction and quantitative methods 3 ECTS credits Part time - 3 Months core Yes
Information and communication about benefit-risk of medicines. Basic principles. 3 ECTS credits Part time - 3 Months core Yes
Introduction to benefit-risk assessment and pharmacoeconomics communication in decision making 3 ECTS Part time - 3 Months core Yes
Pharmacovigilance regulations 3 ECTS credits Part time - 3 Months core Yes
Practical Training core  
Principles of identifying and recognizing adverse events and safety signals 3 ECTS credits Part time - 3 Months core Yes
Principles of pharmacovigilance 3 ECTS credits Part time - 3 Months core Yes
Valorisation and critical appraisal in research 6 ECTS credits Part time - 5 Months core Yes
Advanced Quantitative Benefit-Risk Assessment Methods in Decision Making on Medicines 3 ECTS credits Part time - 3 Months elective Yes
Case studies in medicines risk communication 3 ECTS credits Part time - 3 Months elective Yes
Critical appraisal of clinical trials: evidence-based medicine and its uncertainties 3 ECTS credits Part time - 3 Months elective Yes
Drug utilisation studies: qualitative methods 3 ECTS credits Full time - 3 Months elective Yes
Fundamentals of quantitative benefit-risk assessment methods in decision making on medicines 3 ECTS credits Part time - 3 Months elective Yes
Identifying susceptibility for adverse drug reactions 3 ECTS credits Part time - 3 Months elective Yes
Key roles and stakeholders in medicines risk communication: duties and challenges 3 ECTS credits Part time - 3 Months elective Yes
Methods in clinical research, pharmacoepidemiology and in the assessment of the efficacy of medicines 3 ECTS credits Part time - 3 Months elective Yes
Pharmacovigilance Regulatory Processes 3 ECTS credits Part time - 3 Months elective Yes
Principles of pharmacoeconomics and valuation of health states 3 ECTS credits Part time - 3 Months elective Yes
Substantiation and quantification of risks 6 ECTS credits Part time - 6 Months elective Yes
The public health impact of adverse drug reactions 3 ECTS credits Part time - 3 Months elective Yes
Feedback lifetrain.eu